Embed Size (px)
Citation preview
The ACVP/STP Coalition for Veterinary Pathology Fellows Facilitates Career Advancement Opportunities Gary Cockerell, DVM, PhD, DACVP, Coalition Director
Table 2. Currently Funded Training Positions
Sponsor (Yrs) Academic Inst Academic/Industrial Mentors
Fellow (DVM Institution, Yr)
Anatomic Pathology Residencies
Genentech (2010-2013)
Johns Hopkins Univ Christine Zink/Noël Dybdal
Jennell Bigrigg Romero (Ohio St, ’10)
Amgen (2011-2014)
Univ California, Davis Patricia Pesavento/Jon Werner
Mai Mok (UC Davis, ’11)
Post-Residency PhD Grad Student Positions
Amgen (2010-2013)
Washington St Univ Kevin Lahmers/Esther Trueblood
Kathryn Boland (Mich St, ‘07)
Charles & Sharron Capen (2012-2015)
Auburn Univ Robert Judd/Not Applicable
Emily Graff** (Texas A&M Univ, ’07)
Linda Munson (2012-2015)
Univ California, San Diego
Christina Sigurdson/Not Applicable
Patricia Gaffney* (UC Davis, ’04)
Genentech (2011-2014)
Ohio St Univ Pamela Lucchesi/Noël Dybdal
Kristin Lewis (UC Davis, ’10)
The Coalition for Veterinary Pathology Fellows was established in 2004 as a partnership between the American College of Veterinary Pathologists (ACVP) and the Society of Toxicologic Pathology (STP) to provide a unified mechanism to solicit and allocate funds to train additional veterinary pathologists. To date, 29 Coalition training positions have been funded at 17 different North American universities; 23 Fellows have completed their Coalition training positions (Table 1) and 6 Fellows are currently enrolled in training programs (Table 2).
In addition and to further enhance training in veterinary pathology, this year the Coalition is pleased to announce a new service to facilitate career advancement opportunities. This service, which will be of value to pathology trainees as well as established pathologists, is further explained below.
Introduction
Sponsor (Yrs)Training Inst/Type of Coalition Fellowship
Fellow (DVM Inst, Yr)
Current Position
GlaxoSmithKline (2006-2009)
Univ California/Anat Path Residency
Torrie Crabbs* (NC St, ‘06)
Pathologist, Experimental Pathology Labs, Research Triangle Park, NC
GlaxoSmithKline (2006-2009)
Colorado St Univ/Anat Path Residency
David Gardiner*(Cornell, ‘06)
Pathologist, IDEXX Labs, Sacramento, CA
GlaxoSmithKline (2006-2009)
Univ Illinois/Anat Path Residency
Sandeep Akare* (Nagpur, India, ‘95)
Scientist, Drug Safety, Esai, Andover, MA
Pfizer (2006-2009)
Purdue Univ/Anat Path Residency
Robert Johnson* (Purdue, ‘06)
Principal Research Scientist, Eli Lilly, Indianapolis, IN
Pfizer (2006-2009)
Ohio St Univ/Anat Path Residency
Lyn Wancket (Illinois, ‘06)
PhD graduate program, Nationwide Children’s Hospital, The Ohio St Univ
Pfizer Ricardo Ochoa Minority Fellowship (2006-2009)
Univ Pennsylvania/Anat Path Residency
Melissa Sánchez*(Penn, ‘02)
Lecturer in Anatomic Pathology, School Vet Med, Univ Pennsylvania
Sanofi(2006-2009)
NC St Univ/Anat Path Residency
Danielle Lewis Brown*(NC St, ‘06)
Pathologist, WIL-Biotechnics Res Labs, Hillsborough, NC
Schering-Plough (Merck) (2007-2009)
Ohio St Univ/Post-Residency PhD
Aaron Sargeant*(Ohio St, ‘04)
Pathologist, Charles River Labs, Spencerville, OH
Bristol-Myers Squibb(2007-2010)
Iowa St Univ/Post-Residency PhD
Alicia Olivier*(Miss St, ’05)
Assist Prof, Dept Comp Pathol, Univ Iowa
Merck Research Labs (2007-2010)
Univ Guelph/Clin Path Residency
Janet Beeler-Marfisi** (Guelph, ’07)
Assist Prof, Clinical Pathology, Ross Univ
Genentech(2007-2010)
Univ Guelph/Anat Path Residency
Leah Schutt* (Guelph ‘07)
Assoc Scientist, Pathology, Genentech, So San Francisco, CA
Amgen(2007-2010)
Washington St Univ/Anat Path Residency
Kathryn Boland (Mich St, ‘07)
PhD graduate program, Dept Microbiol & Pathol, Washington St Univ
Eli Lilly(2007-2010)
Michigan St Univ/Anat Path Residency
Jana Ritter*(Georgia, ’07)
Pathologist, St Joseph’s Translational Research Inst, Atlanta, GA
Charles River/Wyeth (Pfizer) (2008-2011)
Iowa St Univ/Anat Path Residency
Angela Pillatzki* (Kansas St, ‘95)
Instructor, Teaching and Diagnostics, Dept Pathol, Iowa St Univ
GlaxoSmithKline(2008-2011)
Texas A&M Univ/Anat Path Residency
Will Sims (Oklahoma St, ‘07)
Pathologist, State Diagnostic Lab, Little Rock, AR
GlaxoSmithKline (2009-2012)
Ohio St Univ/Clin Path Residency
Kelly Santangelo(Cornell, ’04)
Asst Prof, Coll Vet Med & Biomed Sci, Colorado St Univ
GlaxoSmithKline (2009-2012)
Univ California/Anat Path Residency
Victoria Derr-Castillo (Florida, ‘09)
Postdoctoral Fellow, Univ Calif-San Diego
Pfizer (2009-2012)
Univ Minnesota/Anat Path Residency
Mark Chalkley*(Queensland, ’06)
Clinical instructor, Veterinary Pathology, Univ Minnesota
Table 1. Completed Training Positions
79% of fellows (19/24) who have taken the ACVP Certification Examination have passed and 84% of the successful candidates passed all parts on their first attempt. The outstanding success of Coalition fellows on this rigorous examination is a tribute to the quality of the candidates, the excellence of their training programs and the foresight of companies that support the Coalition.
Performance of Fellows on the ACVP Certification Examination
As an outcome of strategic planning and in response to comments received to a Request for Concepts, the Coalition has developed a service to facilitate five different career advancement opportunities:
1. Industrial and Governmental Internships for Post-DVM Pathology Residents 2. Industrial and Governmental Veterinary Pathology Post-Doctoral Fellowships 3. Sabbaticals for Veterinary Pathologists in Academia, Industry and Government 4. Supplemental Industrial Funding for Post-DVM PhD Pathology Graduate Research 5. Recruiting Post-DVM PhD Pathology Graduate Students for Extramurally Funded Training Positions
The service is easy to use – details on how to post information using standardized forms can be found on-line at http://www.vetpathcoalition.org/opportunities. Announcements and more information will also soon appear in ACVP and STP newsletters. In many cases this service will be offered free of charge on a first-time basis, allowing users to compare results with other methods they may have used for similar purposes, or to initiate new career advancement opportunities.
Career Advancement Opportunities
*DACVP, Anat Path **DACVP, Clin Path
Sponsors
To date, sponsors have contributed $6.8M in financial commitments. The Coalition is grateful for the generous contributions from the following organizations and individuals:Alizée Pathology Charles and Sharron Capen GlaxoSmithKline Millennium/Takeda Allergan Charles River Labs Histo-Scientific Res Labs Pfizer Amgen Eli Lilly Instem Sanofi Aperio Elsevier Integrated Lab Systems Schering-PloughBristol-Myers Squibb Experimental Pathol Labs The Leyden Group Wyeth Research Burroughs Wellcome GEMpath Linda Munson Celgene Genentech Merck
For more information on how your organization can participate in the Coalition please see or contact:Coalition web site, http://www.vetpathcoalition.org/Mark Cline, Chair, Coalition Board of Governors, (336) 716-1564, [email protected] Cockerell, Coalition Director, (269) 720-7310, [email protected] Rees, Coalition Administrative Office, (608) 443-3645 x138, [email protected]
Sponsor (Yrs)Training Inst/Type of Coalition Fellowship
Fellow (DVM Inst, Yr)
Current Position
Pfizer Ricardo Ochoa Minority Fellowship (2009-2012)
Univ Georgia/Anat Path Residency
Bala Manickam*(Pondicherry, India, 02’)
Principal Investigator, Seventh Wave Labs, St Louis, MO
Pfizer(2009-2012)
Michigan St Univ/Clin Path Residency
Charlotte Hollinger**(Penn, ’08)
Anat Pathol Residency, Michigan St Univ
Sanofi(2009-2012)
Texas A&M UnivPost-Residency PhD
Catherine Pfent(Mich St, ‘07)
PhD graduate program, Texas A&M Univ
Schering-Plough (Merck) (2009-2012)
Johns Hopkins UnivPost-Residency PhD
Kathleen Brennan* (NCSU, ‘03)
To be determined
Bristol-Myers Squibb (2009-2012)
Michigan St UnivPost-Residency PhD
Dodd Sledge* (Georgia, ‘06)
Academic Specialist, Michigan St Univ
Table 1. Completed Training Positions (continued)
